Over the last 7 days, the Healthcare industry has dropped 1.7%, driven by a pullback from Merck of 9.5%. Meanwhile, Moderna actually outperformed within the industry, gaining 28% in the last week. This takes the industry's 12 month performance to a gain of 13%.
Has the U.S. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Wed, 01 Dec 2021 | US$6.6t | US$2.4t | US$146.5b | 30.6x |
| Fri, 29 Oct 2021 | US$6.8t | US$2.3t | US$127.3b | 34x |
| Sun, 26 Sep 2021 | US$6.9t | US$2.3t | US$120.1b | 36.1x |
| Tue, 24 Aug 2021 | US$6.9t | US$2.3t | US$121.2b | 33.3x |
| Wed, 30 Jun 2021 | US$6.6t | US$2.3t | US$113.6b | 32.4x |
| Sat, 03 Apr 2021 | US$6.0t | US$2.4t | US$93.5b | 29x |
| Tue, 05 Jan 2021 | US$5.8t | US$2.3t | US$87.0b | 29.3x |
| Fri, 09 Oct 2020 | US$5.1t | US$2.3t | US$104.6b | 28.7x |
| Thu, 02 Jul 2020 | US$4.8t | US$2.4t | US$101.2b | 31.4x |
| Sun, 05 Apr 2020 | US$3.9t | US$2.4t | US$99.2b | 28.8x |
| Wed, 08 Jan 2020 | US$4.5t | US$2.3t | US$100.0b | 29.1x |
| Tue, 01 Oct 2019 | US$3.8t | US$2.3t | US$84.2b | 26.2x |
| Fri, 05 Jul 2019 | US$4.0t | US$2.2t | US$96.2b | 28.2x |
| Mon, 08 Apr 2019 | US$3.9t | US$2.1t | US$84.5b | 28x |
| Thu, 10 Jan 2019 | US$3.7t | US$2.0t | US$68.5b | 25x |
27.8x
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 30.0x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 35% per year over the last three years, and revenues for these companies have grown 6.6% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the U.S. Healthcare sector?
| Biotech | 1.27% | |
| Life Sciences | 0.73% | |
| Healthtech | -0.84% | |
| Pharma | -3.03% | |
| Healthcare Services | -3.56% | |
| Medical Equipment | -3.67% | |
Industry PE: Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 67.0x. This is likely because analysts are expecting annual earnings growth of 34%, which is higher than its past year's earnings growth of 17% per year. Meanwhile, investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 20.3x.
Forecasted Growth: Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 34% over the next 5 years. This is better than it's past earnings growth rate of 17% per year. Meanwhile, the Life Sciences industry is expected to see its earnings grow by 7.8% per year over the next few years.
Which companies have driven the market over the last 7 days?
| Company | 7D | 1Y | Valuation | |
|---|---|---|---|---|
| MRNA Moderna | 27.5%+US$30.8b | 149.9% | PE20.2x | |
| PFE Pfizer | 5.2%+US$14.9b | 36.3% | PE15.4x | |
| BNTX BioNTech | 13.9%+US$10.4b | 208.5% | PE10.1x | |
| DHR Danaher | 2.6%+US$5.8b | 43.0% | PE40.8x | |
| ADGI Adagio Therapeutics | 155.2%+US$3.2b | n/a | PB8.3x |
